The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
LDN Community
Join our community here.
Low-dose naltrexone (LDN)—review of therapeutic utilization
Med Sci (Basel)
21 September 2018
https://pubmed.ncbi.nlm.nih.gov/30248938/
Use of LDN for Chronic Pain - Sahar Swidan, PHARM.D., ABAAHP, FAARFM, FACA (2021 Conference) (LDN, low dose naltrexone)
This talk is on the use of LDN for chronic pain. She reviews LDN’s actions in the CNS and the PNS, the immunomodulating effect of LDN, and some clinical trials on the use of LDN.
Hypothyroidism - Dawn Ipsen, PharmD (2021 Conference) (LDN, low dose naltrexone)
Dr. Dawn Ipsen is a compounding pharmacist who presents on some roles low dose naltrexone (LDN) may have in helping patients with hypothyroidism. She discusses hypothyroidism, its prevalence, and treatment goals.
Crohn’s - Pamela Smith, MD, MS (2021 Conference) (LDN, low dose naltrexone)
Dr. Pamela Smith discusses Crohn’s, an autoimmune disease, from both a conventional and personalized medicine approach. Siting research and her own clinical experience, Dr. Smith discusses traditional and complementary treatment, dietary and nutritional therapies, as well as the use of Low Dose Naltrexone in treating Crohn’s Disease.
Paul Battle, PA-C - Crohn’s Disease (2016 Conference) (LDN, low dose naltrexone)
SIBO - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)
Restless Leg Syndrome - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)
This lecture starts with the known and newer pathophysiology to try to uncover new ways of treating restless legs syndrome (RLS). Using case studies, he links RLS with small intestinal bacterial overgrowth (SIBO), low iron, and other autoimmune disorders. Treatment examples are provided
Nuts and Bolts of The Thyroid Gland: Therapeutic Targets by Sarah Zielsdorf, MD (2021 Conference) (LDN, low dose naltrexone)
The role of immune modulation in cancer - Professor Angus Dalgleish (2021 Conference) (LDN, low dose naltrexone)
History, Pharmacology and Mechanism - Stephen Dickson, BSC (hons) MRPharmS (2021 Conference) (LDN, low dose naltrexone)
LDN Research Trust 2021 Conference - Friday Morning